R. Wilson (London, United Kingdom), O. Culic (Zagreb, Croatia)
Respiratory impact and quality of life in patients with common variable immunodeficiency receiving subcutaneous IgG replacement therapy
S. E. Bergstrom, R. Gustafson, L. Lagerstrand, S. Hansen, C. I. E. Smith, L. Hammarstrom, A. Gardulf (Stockholm, Huddinge, Sweden)
|   ![]()  ![]() |
Effect of azithromycin on FEV1 and exacerbation frequency in adult non-cystic fibrosis bronchiectasis
G. A. Anwar, C. Ward, S. Bourke, G. Afolabi, P. Middleton, R. Rutherford (North Shields, Newcastle upon Tyne, United Kingdom)
| |
High resolution computer tomography and pulmonary function in common variable immunodeficiency
S. Gregersen, T. M. Aaløkken, G. Mynarek, J. Kongerud, S. S. Frøland, B. Johansen (Oslo, Norway)
| ![]() ![]() |
Serological test and chest computed tomography findings in patients with mycobacterium avium-intracellulare (MAC) lung disease
R. Maekura, S. Kitada, T. Hiraga, Y. Nishiuti, K. Kobayashi (Toyonaka, Osaka, Tokyo, Japan)
| ![]() ![]() |
Systemic inflammation and colonization in patients with clinically stable bronchiectasis
B. Ergan Arsava, L. Coplu, A. A. Sahin (Ankara, Turkey)
| |
Bronchiectasis in a district general hospital: aetiology and characteristics
M. Heightman, S. Cone, L. Phee, S. Quantrill (London, United Kingdom)
| ![]() ![]()  |
Outcome of dedicated immune profiling in adult non-cystic fibrosis bronchiectasis
G. A. Anwar, S. Bourke, G. Afolabi, P. Middleton, C. Ward, R. Rutherford (North Shields, Newcastle upon Tyne, United Kingdom)
| |
Longitudinal decline in FEV1 in an adult non-cystic fibrosis bronchiectasis cohort
G. A. Anwar, S. Bourke, G. Afolabi, C. Ward, P. Middleton, N. Wong, L. Murray, R. Rutherford (North Shields, Newcastle upon Tyne, United Kingdom)
| |